RITE3
Summary of public USPTO data
- Owner
- SEED Therapeutics US, Inc.
- Status
- Live/Registered
- Serial number
- 98727351
- Registration number
- 8245651
- Filing date
- 2024-08-30
- Registration date
- 2026-05-05
- International classes
- 42
Goods and services
Class 42
- drug discovery, pharmaceutical drug development, and drug validation services in the field of targeted disease-causing or disease-associated protein degradation
- pharmaceutical research and development services, in particular for identifying ubiquitin ligases
- providing medical research and scientific information related to ubiquitin ligase identification and targeted disease-causing or disease-associated protein degradation in the fields of pharmaceuticals, biological life sciences, chemistry, biochemistry, biotechnology, and clinical trials
- providing scientific, and medical research information related to targeted disease-causing or disease-associated protein degradation in the field of pharmaceutical and clinical trials via the internet
- consulting services in the fields of pharmaceutical research, biological life sciences, pharmaceutical chemistry, biochemistry, biotechnology, clinical trials, all related to targeted disease-causing or disease-associated protein degradation
- research and development of new products in the field of targeted disease-causing or disease-associated protein degradation and the identification of ubiquitin ligases
- pharmaceutical, scientific, medical, and clinical research and development services in the field of targeted disease-causing or disease-associated protein degradation
- providing information about scientific, pharmaceutical, clinical, and medical research, namely, drug discovery, development and validation information related to a method of ligase selection to discover molecules and drugs that cause targeted disease-causing or disease-associated protein degradation
- Scientific and technological services, namely, technical biology consulting services, in particular for identifying ubiquitin ligases